Evaluation of Bone Metabolism in Critically Ill Patients Using CTx and PINP.

Alexandra Gavala, Konstantinos Makris, Anna Korompeli, Pavlos Myrianthefs

Journal: BioMed research international 2017;2016():1951707

PMID: 28025639

Abstract

. Prolonged immobilization, nutritional and vitamin D deficiency, and specific drug administration may lead to significant bone resorption. . We prospectively evaluated critically ill patients admitted to the ICU for at least 10 days. Demographics, APACHE II, SOFA scores, length of stay (LOS), and drug administration were recorded. Blood collections were performed at baseline and on a weekly basis for five consecutive weeks. Serum levels of PINP, -CTx, iPTH, and 25(OH)vitamin D were measured at each time-point. . We enrolled 28 patients of mean age 67.4 ± 2.3 years, mean APACHE II 22.2 ± 0.9, SOFA 10.1 ± 0.6, and LOS 31.6 ± 5.7 days. Nineteen patients were receiving low molecular weight heparin, 17 nor-epinephrine and low dose hydrocortisone, 18 transfusions, and 3 phenytoin. 25(OH)vitamin D serum levels were very low in all patients at all time-points; iPTH serum levels were increased at baseline tending to normalize on 5th week; -CTx serum levels were significantly increased compared to baseline on 2nd week (peak values), whereas PINP levels were increased significantly after the 4th week. . Our data show that critically ill patients had a pattern of hypovitaminosis D, increased iPTH, hypocalcaemia, and BTMs compatible with altered bone metabolism.

Address: School of Health Sciences, Department of Nursing, "Agioi Anargyroi" General Hospital, National and Kapodistrian University of Athens, Noufaron & Timiou Stavrou, 14564 Kaliftaki, Nea Kifissia, Athens, Greece.; Clinical Biochemistry Department, KAT General Hospital, Kifissia, Athens, Greece.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.